---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-020878"
form_type: "8-K"
ticker: "ECOR"
cik: "0001560258"
company_name: "electroCore, Inc."
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:16:55.336445+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# electroCore Q3 net sales $8.7M up 33% YoY; raises FY2025 revenue guidance to $31.5-$32.5M

## Summary
- Net sales $8.7M, 33% increase YoY; YTD net sales $22.8M, up 26% vs first nine months of 2024.
- Net loss $3.4M ($0.40 per share) vs $2.5M loss in Q3 2024; adjusted EBITDA net loss $2.0M vs $2.1M.
- FY2025 revenue guidance raised to $31.5-$32.5M; expects first quarter of positive adjusted EBITDA in H2 2026.
- Total cash $13.2M at Sep 30, 2025, up from $12.2M at Dec 31, 2024.
- Prescription devices sales $6.81M (+19% YoY); health & wellness $1.88M (+121% YoY).

## SEC filing metadata
- accession: 0001493152-25-020878
- form_type: 8-K
- ticker: ECOR
- cik: 0001560258
- company_name: electroCore, Inc.
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560258/000149315225020878/0001493152-25-020878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560258/000149315225020878/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-020878
- JSON: https://secwatch.observer/filing/0001493152-25-020878.json
- Plain text: https://secwatch.observer/filing/0001493152-25-020878.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.